ArticleJournal of general internal medicine2018
Utilization of breast cancer screening with magnetic resonance imaging in community practice.
Article in Journal of general internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 36 citations in OpenAlex.
- Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial.JNCI cancer spectrum · 2021Trial
- Reported Breast MRI Among U.S. Women Undergoing Screening Mammography: a National Cross-Sectional Study.Journal of general internal medicine · 2026Article
- Awareness of magnetic resonance imaging for early detection of breast cancer: A cross-sectional study.The Journal of international medical research · 2025Article
- Reported Mammography Screening Interval by Age Among U.S. Women: A National Cross-Sectional Study.Annals of internal medicine · 2025Article
- Factors influencing U.S. women's interest and preferences for breast cancer risk communication: a cross-sectional study from a large tertiary care breast imaging center.BMC women's health · 2024Article
- Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery.Biomedicines · 2024Review
- Predictors of nonadherence to breast cancer screening guidelines in a United States urban comprehensive cancer center.Cancer medicine · 2023Article
- Predicting breast cancer risk in a racially diverse, community-based sample of potentially high-risk women.Cancer medicine · 2022Article
- Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density.Breast cancer research and treatment · 2022Article
- Downstream Mammary and Extramammary Cascade Services and Spending Following Screening Breast Magnetic Resonance Imaging vs Mammography Among Commercially Insured Women.JAMA network open · 2022Article
- Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening.Journal of the National Cancer Institute · 2022Observational
- Diagnostic Value of Dynamic Enhanced Magnetic Resonance Imaging Combined with Serum CA15-3, CYFRA21-1, and TFF1 for Breast Cancer.Journal of healthcare engineering · 2022Article
- Integrity of clinical information in radiology reports documenting pulmonary nodules.Journal of the American Medical Informatics Association : JAMIA · 2021Article
- ADNEX Model-Based Diagnosis of Ovarian Cancer Using MRI Images.Contrast media & molecular imaging · 2021Article
- Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016.Cancer · 2020Observational
- The low expression of miR-1976 in plasma samples indicating its biological functions in the progression of breast cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020Article
- Diagnosis of Benign and Malignant Breast Lesions on DCE-MRI by Using Radiomics and Deep Learning With Consideration of Peritumor Tissue.Journal of magnetic resonance imaging : JMRI · 2020Article
- Family health history: underused for actionable risk assessment.Lancet (London, England) · 2019Review
- Differences between screen-detected and interval breast cancers among BRCA mutation carriers.Breast cancer research and treatment · 2019Article
- Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019Article
Corrections and comments
- Commented on by
Authors and funding
12 authors at 10 institutions in 1 country.
Funding
Abstract
backgroundBreast cancer screening with magnetic resonance imaging (MRI) may be a useful adjunct to screening mammography in high-risk women, but MRI uptake may be increasing rapidly among low- and average-risk women for whom benefits are unestablished. Comparatively little is known about use of screening MRI in community practice.
objectiveTo assess relative utilization of MRI among women who do and do not meet professional society guidelines for supplemental screening, and describe utilization according to breast cancer risk indications.
designProspective cohort study conducted between 2007 and 2014.
participantsIn five regional imaging registries participating in the Breast Cancer Surveillance Consortium (BCSC), 348,955 women received a screening mammogram, of whom 1499 underwent screening MRI. MAIN MEASURES: Lifetime breast cancer risk (< 20% or ≥ 20%) estimated by family history of two or more first-degree relatives, and Gail model risk estimates. Breast Imaging Reporting and Data System breast density and benign breast diseases also were assessed. Relative risks (RR) for undergoing screening MRI were estimated using Poisson regression. KEY
resultsAmong women with < 20% lifetime risk, which does not meet professional guidelines for supplementary MRI screening, and no first-degree breast cancer family history, screening MRI utilization was elevated among those with extremely dense breasts [RR 2.2; 95% confidence interval (CI) 1.7-2.8] relative to those with scattered fibroglandular densities and among women with atypia (RR 7.4; 95% CI 3.9-14.3.) or lobular carcinoma in situ (RR 33.1; 95% CI 18.0-60.9) relative to women with non-proliferative disease. Approximately 82.9% (95% CI 80.8%-84.7%) of screening MRIs occurred among women who did not meet professional guidelines and 35.5% (95% CI 33.1-37.9%) among women considered at low-to-average breast cancer risk.
conclusionUtilization of screening MRI in community settings is not consistent with current professional guidelines and the goal of delivery of high-value care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.